diosgenin has been researched along with Lung Injury, Acute in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cai, J; Chen, Y; Yang, L; Zeng, H; Zhang, X | 1 |
Chen, L; Gao, M; Kou, J; Sun, Q; Yu, B; Yu, H | 1 |
2 other study(ies) available for diosgenin and Lung Injury, Acute
Article | Year |
---|---|
Dioscin prevents LPS‑induced acute lung injury through inhibiting the TLR4/MyD88 signaling pathway via upregulation of HSP70.
Topics: Acute Lung Injury; Animals; Cytokines; Diosgenin; HSP70 Heat-Shock Proteins; Lipopolysaccharides; Male; Mice; Myeloid Differentiation Factor 88; Signal Transduction; Toll-Like Receptor 4; Up-Regulation | 2018 |
Diosgenin down-regulates NF-κB p65/p50 and p38MAPK pathways and attenuates acute lung injury induced by lipopolysaccharide in mice.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Cell Line; Cell Movement; Dioscorea; Diosgenin; Disease Models, Animal; Down-Regulation; Humans; Lipopolysaccharides; Lung; Male; Medicine, Chinese Traditional; Mice; Mice, Inbred ICR; Monocytes; p38 Mitogen-Activated Protein Kinases; Signal Transduction; Transcription Factor RelA | 2013 |